Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.59 |
| ▸ | ATM | Q13315 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.49 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.49 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.49 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.49 |
| ▸ | KLK7 | P49862 | 2/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27871613 | 0.98 | L3MBTL1 (0.58) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL8652438 | 0.98 | L3MBTL1 (0.58) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL1550630 | 0.98 | L3MBTL1 (0.58) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL10911370 | 0.98 | L3MBTL1 (0.58) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL28722007 | 0.98 | L3MBTL1 (0.58) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL1395561 | 0.88 | L3MBTL1 (0.49) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL27635695 | 0.88 | PTGS1 (0.55) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL1489979 | 0.87 | L3MBTL1 (0.51) | L3MBTL1ATMTDP1CHRM1CHRM3 | |
| SCHEMBL11603067 | 0.83 | L3MBTL1 (0.59) | L3MBTL1ATMTDP1LMNACYP1A2 | |
| P-Cresol SCHEMBL1867060 | 0.81 | L3MBTL1 (0.54) | L3MBTL1ATMCHRM1CHRM3CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025243208-A2 | PROCESS FOR THE PREPARATION AND/OR PURIFICATION OF POLYETHYLENE GLYCOL AND ITS DERIVATIVES, OBTAINED PRODUCT AND USES THEREOF | HOVIONE - FARMACIÊNCIA, SA (PT) | 2025-11-27 | — | — | WO | claimed |
| WO-2024046339-A1 | PHARMACEUTICAL FORMULATION COMPRISING COMBINATION OF LONG-ACTING INHALED STEROID AND LONG-ACTING β2 RECEPTOR AGONIST | 立生医药(苏州)有限公司 | 2024-03-07 | — | — | WO | claimed |
| US-20240018147-A1 | SALT OF COMPOUND FOR DEGRADING BTK, CRYSTAL FORM THEREOF, AND USE THEREOF IN MEDICINE | HAISCO PHARMACEUTICALS PTE. LTD. (CN) | 2024-01-18 | — | — | US | claimed |
| EP-4212534-A1 | SALT OF COMPOUND FOR DEGRADING BTK, CRYSTAL FORM THEREOF, AND USE THEREOF IN MEDICINE | Haisco Pharmaceuticals Pte. Ltd. (SG) | 2023-07-19 | — | — | EP | claimed |
| CN-115073391-B | Novel crystal form of pramipexole triphenacetate and preparation method thereof | 山东京卫制药有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-218653369-U | Filtering and concentrating device for crude product of triphenylacetic acid | 安徽有吉医药科技有限公司 | 2023-03-21 | — | — | CN | claimed |
| CN-115215818-B | Pramipexole triphenyl acetate and drug sustained release preparation thereof | 山东京卫制药有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-115802893-A | Fungicidal compositions | 先正达农作物保护股份公司 | 2023-03-14 | — | — | CN | claimed |
| CN-115745945-A | Method for preparing vilanterol intermediate by one-pot method | 奥锐特药业股份有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-115721625-A | Pharmaceutical composition containing mirabegron and preparation and application thereof | 山东威智中科药业有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-112876507-A | Trisubstituted olefin tertiary phosphine compound and preparation method thereof | 湖北大学 | 2021-06-01 | — | — | CN | claimed |
| CN-112262852-A | Triphenylacetic acid tin dispersible oil suspending agent and preparation method thereof | 浙江禾本科技股份有限公司 | 2021-01-26 | — | — | CN | claimed |
| CN-111807973-A | Preparation method of vilanterol and salt thereof | 上海谷森医药有限公司 | 2020-10-23 | — | — | CN | claimed |
| CN-110740644-A | Fungicidal compositions | 先正达参股股份有限公司 | 2020-01-31 | — | — | CN | claimed |
| US-20150239862-A1 | PROCESS FOR THE PREPARATION OF VILANTEROL AND INTERMEDIATES THEREOF | PERRIGO API LTD. (IL) | 2015-08-27 | — | — | US | claimed |
| WO-2014041565-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF VILANTEROL AND INTERMEDIATES THEREOF | LAURUS LABS PRIVATE LIMITED (IN) | 2014-03-20 | — | — | WO | claimed |
| EP-1431984-A1 | Polymer resistor composition having a substantially neutral temperature coefficient of resistance and methods and compositions relating thereto | E. I. du Pont de Nemours and Company (US) | 2004-06-23 | — | — | EP | claimed |
| US-20040113127-A1 | Resistor compositions having a substantially neutral temperature coefficient of resistance and methods and compositions relating thereto | E.I. DU PONT DE NEMOURS AND COMPANY | 2004-06-17 | — | — | US | claimed |
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-4332962-A | RHODIUM COMPOUND AS CATALYST FOR CYCLIZATION OF A PENTADIENE | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1982-06-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150239862-A1 | PROCESS FOR THE PREPARATION OF VILANTEROL AND INTERMEDIATES THEREOF | VAT1, VKORC1L1, VKORC1 | L3MBTL1 4322/4885ATM 4711/4885TDP1 3521/4885 |
| US-20240018147-A1 | SALT OF COMPOUND FOR DEGRADING BTK, CRYSTAL FORM THEREOF, AND USE THEREOF IN MEDICINE | BTK, SYK, LYN | L3MBTL1 3286/4885ATM 197/4885TDP1 1553/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.